Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Chinese Postmenopausal Women With Osteoporosis
NCT02014467Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2014
- Primary completion
- Aug 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in postmenopausal osteoporosis, sponsored by GSK. Started Jan 2014; status: completed.
02
Drugs
denosumab
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT02014467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02014467.